-
EP3581587
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3581587
| EP3581587 - ANTI-COAGULATION FACTOR XI ANTIBODY [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 15.11.2019 Database last updated on 12.07.2024 | |
| Former | The international publication has been made Status updated on 18.08.2018 | Most recent event Tooltip | 05.07.2024 | Change - German title | published on 07.08.2024 [2024/32] | Applicant(s) | For all designated states Shanghai Benemae Pharmaceutical Corporation No. 916 Ziping Rd. Zhoupu Town Pudong New Area Shanghai 201321 / CN | [2019/51] | Inventor(s) | 01 /
WANG, Wenyi No. 916 Ziping Road Zhoupu Town Pudong New Area Shanghai 201321 / CN | 02 /
YU, Quan No. 916 Ziping Road Zhoupu Town Pudong New Area Shanghai 201321 / CN | 03 /
LIU, Xiaowu No. 916 Ziping Road Zhoupu Town Pudong New Area Shanghai 201321 / CN | [2019/51] | Representative(s) | Gulde & Partner Patent- und Rechtsanwaltskanzlei mbB Wallstraße 58/59 10179 Berlin / DE | [2019/51] | Application number, filing date | 17895532.4 | 29.12.2017 | [2019/51] | WO2017CN119856 | Priority number, date | CN20171073984 | 10.02.2017 Original published format: CN201710073984 | [2019/51] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018145533 | Date: | 16.08.2018 | Language: | ZH | [2018/33] | Type: | A1 Application with search report | No.: | EP3581587 | Date: | 18.12.2019 | Language: | EN | [2019/51] | Search report(s) | International search report - published on: | CN | 16.08.2018 | (Supplementary) European search report - dispatched on: | EP | 02.03.2021 | Classification | IPC: | C07K16/36, C12N15/13, C12N15/85, A61K39/395, A61P7/02, A61P31/04 | [2019/51] | CPC: |
A61P7/02 (EP);
C07K16/36 (EP,CN,KR);
A61P31/04 (EP,KR);
C12N15/85 (CN);
A61K2039/505 (EP,CN,KR);
C07K2317/24 (EP,KR);
C07K2317/33 (EP);
C07K2317/565 (EP,CN);
C07K2317/76 (EP,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/51] | Title | German: | ANTI-GERINNUNGSFAKTOR-XI ANTIKÖRPER | [2024/32] | English: | ANTI-COAGULATION FACTOR XI ANTIBODY | [2019/51] | French: | ANTICORPS ANTI-FACTEUR XI DE COAGULATION | [2019/51] |
| Former [2019/51] | GERINNUNGSHEMMENDER FAKTOR-XI-ANTIKÖRPER | Entry into regional phase | 23.08.2019 | Translation filed | 23.08.2019 | National basic fee paid | 23.08.2019 | Search fee paid | 23.08.2019 | Designation fee(s) paid | 23.08.2019 | Examination fee paid | Examination procedure | 23.08.2019 | Examination requested [2019/51] | 29.09.2021 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 23.08.2019 | Renewal fee patent year 03 | 14.12.2020 | Renewal fee patent year 04 | 16.12.2021 | Renewal fee patent year 05 | 14.11.2022 | Renewal fee patent year 06 | 15.11.2023 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2009067660 (UNIV OREGON HEALTH & SCIENCE [US], et al) |